086. Global Fungal Infections
Thursday, October 5, 2017: 2:00 PM-3:30 PM
Room: 15AB
Co-organized with the National Institute of Allergy and Infectious Diseases

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • review the global impact of systemic fungal infections
  • describe the challenges in diagnosis and management of invasive fungal infections in resource-limited settings
  • recognize the impact of cryptococcal infection on mortality in HIV disease

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, HIV clinicians, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Medical students and residents, Members-in-training, Microbiologists, Pharmacists, Public health practitioners, Researchers

Tracks: Adult ID, Trainee, Pediatric ID, Investigative ID, Global ID

Moderators:  William G. Powderly, MD, FIDSA, Washington University in St. Louis and Michail Lionakis, MD, ScD, NIH

2:00 PM
The Global Impact of Mold Infections
David Denning, MD FRCP FIDSA

2:25 PM
Endemic Mycoses in Latin America
Beatriz L. Gomez, PhD

3:15 PM

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-250-L01-P


W. G. Powderly, Merck: Consultant and Grant Investigator , Consulting fee and Grant recipient
Gilead: Consultant , Consulting fee
Astellas: Grant Investigator , Grant recipient
MiraVista: Grant Investigator , Grant recipient

M. Lionakis, Viamet Inc: Grant recipient , Grant recipient
Matinas BioPharma: Grant recipient , Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.